Immutep Limited

IMM.ASX

Health Care

biotechnology and medical research

Market Data

Price

$0.050

+0.0%

Market Cap

$72.2M

P/E Ratio

-100000.0x

EPS

$-0.057

Div. Yield

0.00%

52-Week Change

-0.8%

Recent Announcements

1 Jul 2026 Sph Neutral

Ceasing to be a substantial holder

JPMorgan Chase & Co. and its affiliates ceased to be a substantial holder.

17 Jun 2026 Sph Neutral

Becoming a substantial holder

JPMorgan Chase & Co. and its affiliates became a substantial holder (5.20%).

16 Jun 2026 Sph Neutral

Ceasing to be a substantial holder

JPMorgan Chase & Co. and its affiliates ceased to be a substantial holder.

15 Jun 2026 Sph Neutral

Becoming a substantial holder

JPMorgan Chase & Co. and its affiliates became a substantial holder (5.28%).

10 Jun 2026 Sph Neutral

Ceasing to be a substantial holder

JPMorgan Chase & Co. and its affiliates ceased to be a substantial holder.

9 Jun 2026 Sph Neutral

Ceasing to be a substantial holder

Regal Partners Funds Management Pty Ltd and its ceased to be a substantial holder.

9 Jun 2026 Sph Neutral

Becoming a substantial holder

JPMorgan Chase & Co. and its affiliates became a substantial holder (5.20%).

11 May 2026 Sph Neutral

Ceasing to be a substantial holder

JPMorgan Chase & Co. and its affiliates ceased to be a substantial holder.

19 Mar 2026 Sph Neutral

Ceasing to be a substantial holder from IFL

IFL ceased to be a substantial holder.

18 Mar 2026 Sph Neutral

Ceasing to be a substantial holder

UBS Group AG ceased to be a substantial holder.

Get real-time alerts for IMM

Receive AI-powered earnings summaries and instant notifications when Immutep Limited releases results.